Vir Biotechnology Inc (VIR) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $9.32
• Market Cap: $1.39B
• EPS: $-3.62
• 52-Week High: $10.94
• 52-Week Low: $4.16

Market Sentiment

Vir Biotechnology Inc currently has a Bullish sentiment score of 0.31.

About Vir Biotechnology Inc

Vir Biotechnology, Inc. is a clinical-stage immunology company headquartered in San Francisco, California, focused on leveraging its proprietary technologies to develop therapeutic solutions for serious infectious diseases. With a robust pipeline targeting viral pathogens, including its innovative monoclonal antibodies and immunotherapeutics, Vir aims to address unmet medical needs in areas such as COVID-19 and influenza. The company's strategic partnerships and collaborations enhance its res...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Vir Biotechnology Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VIR pay dividends?

Vir Biotechnology Inc (VIR) does not currently pay a regular dividend.

What is VIR's market cap?

Vir Biotechnology Inc (VIR) has a market capitalization of $1.39B with a current stock price of $9.32.